Category: Gene Therapy
Gene Therapy market research reports by Global Insight Services
-
Cell Therapy Market Analysis and Forecast to 2033: By Cell Type (Stem, T-Cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), Therapeutic Area (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Dermatological Disorders, Others), Application (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-Based Assays, Others), End-User (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), Stage Of Development (Preclinical, Phase I, Phase II, Phase III, Commercialized), Technology (Viral Vector-Based, Non-Viral Vector-Based, Gene Editing Technologies), Mode Of Delivery (Intravenous, Intramuscular, Subcutaneous, Others), and Region
Cell Therapy Market Analysis and Forecast to 2033: By Cell Type (Stem, T-Cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), Therapeutic Area (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Derm ... Read More
-
Cell Therapy Market. - forecast to 2033 : By CELL TYPE (Stem, T-cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), THERAPEUTIC AREA (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Dermatological Disorders, Others), APPLICATION (Regenerative Medicine, Tissue Engineering, Immunotherapy, Gene Therapy, Cell-based Assays, Others), END-USER (Hospitals & Clinics, Research Institutes, Biotechnology, Pharmaceutical Companies), STAGE OF DEVELOPMENT (Preclinical, Phase I, Phase II, Phase III, Commercialized), TECHNOLOGY (Viral Vector-based, Non-viral Vector-based, Gene Editing Technologies), MODE OF DELIVERY (Intravenous, Intramuscular, Subcutaneous, Others), and Region
Cell Therapy Market. - forecast to 2033 : By CELL TYPE (Stem, T-cell Therapy, Dendritic, Natural Killer, Mesenchymal Stem Cell, Induced Pluripotent Stem Cell), THERAPEUTIC AREA (Oncology, Cardiovascular Disorders, Neurological Disorders, Musculoskeletal Disorders, Autoimmune Disorders, Dermatologica ... Read More
-
Microcarrier Market Analysis and Forecast to 2033: By Product (Consumables and Equipment), Application (Biopharmaceutical Production, Cell & Gene Therapy, Tissue Engineering, and Others), End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and Region
Microcarrier Market Analysis and Forecast to 2033: By Product (Consumables and Equipment), Application (Biopharmaceutical Production, Cell & Gene Therapy, Tissue Engineering, and Others), End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and Region A microcarr ... Read More
Research Assistance
